InspireMD

InspireMD, Inc., is a medical device company that is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases. InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable stroke free long-term outcomes. InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS and NSPR.WSB. The company is based in Tel Aviv, Israel.